| scholarly article | Q13442814 |
| P50 | author | Maria Teresa Scupoli | Q59680924 |
| Giorgio Malpeli | Q63866098 | ||
| George A. Calin | Q64785850 | ||
| Simonetta Zupo | Q85992816 | ||
| Paul Takam Kamga | Q87441291 | ||
| P2093 | author name string | Matteo Brunelli | |
| Carlo Maria Croce | |||
| Aldo Scarpa | |||
| Alberto Zamò | |||
| Serena Pedron | |||
| Stefano Barbi | |||
| Mauro Krampera | |||
| Gabriele Tosadori | |||
| Anna Bertolaso | |||
| Corinna Greco | |||
| P2860 | cites work | miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth | Q36341406 |
| miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database | Q36434925 | ||
| High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival | Q36561781 | ||
| Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics | Q36721503 | ||
| The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit. | Q37024999 | ||
| Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma | Q37100081 | ||
| MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways | Q37166300 | ||
| Regulation of B-cell differentiation by microRNAs and RNA-binding proteins. | Q37330371 | ||
| The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop. | Q37405472 | ||
| MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression | Q37580183 | ||
| Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 | Q37706993 | ||
| The impact of MYC expression in lymphoma biology: Beyond Burkitt lymphoma | Q37785375 | ||
| Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes | Q38071077 | ||
| MicroRNAs as regulators and mediators of c-MYC function | Q38204153 | ||
| Genetic landscape and deregulated pathways in B-cell lymphoid malignancies | Q38669131 | ||
| miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis | Q38780780 | ||
| MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway. | Q38804358 | ||
| miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164. | Q39001815 | ||
| Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. | Q39004690 | ||
| Finding the shortest path with PesCa: a tool for network reconstruction | Q39249772 | ||
| Establishment of the MAVER-1 cell line, a model for leukemic and aggressive mantle cell lymphoma. | Q40325588 | ||
| An allelic series of miR-17 ∼ 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron | Q40883914 | ||
| Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma | Q41211534 | ||
| Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling | Q42503470 | ||
| Micro-RNA Expression and Function in Lymphomas | Q42703031 | ||
| Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma | Q42923456 | ||
| The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry | Q43091743 | ||
| Molecular diagnosis of Burkitt's lymphoma | Q45207362 | ||
| Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents | Q47859763 | ||
| miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential. | Q51817287 | ||
| Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway. | Q52662491 | ||
| A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial. | Q52730895 | ||
| Low expression of miRNA-224 predicts poor clinical outcome in diffuse large B-cell lymphoma treated with R-CHOP. | Q53368987 | ||
| MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma | Q57272181 | ||
| MicroRNA expression in lymphocyte development and malignancy | Q57976149 | ||
| MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas | Q81418207 | ||
| MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia | Q82828892 | ||
| Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement | Q84596868 | ||
| Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas | Q24301269 | ||
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex | Q24599546 | ||
| Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters | Q24645192 | ||
| Widespread microRNA repression by Myc contributes to tumorigenesis | Q24647067 | ||
| Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas | Q24652219 | ||
| Global mapping of c-Myc binding sites and target gene networks in human B cells | Q24675083 | ||
| MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
| A microRNA polycistron as a potential human oncogene | Q27860720 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
| Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray | Q28204313 | ||
| MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb | Q29619411 | ||
| Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental data. | Q30660579 | ||
| Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis | Q33573515 | ||
| MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state | Q34314932 | ||
| Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer | Q34377430 | ||
| Gene expression profiling of lymphoid malignancies | Q34511542 | ||
| Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma | Q35080097 | ||
| A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma | Q35084573 | ||
| MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation | Q35741642 | ||
| MicroRNA signatures in B-cell lymphomas. | Q35783359 | ||
| microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13. | Q35937111 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 51 | |
| P304 | page(s) | 29753-29771 | |
| P577 | publication date | 2018-07-03 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways | |
| P478 | volume | 9 |
Search more.